BCM
IMAX icon

Bayesian Capital Management’s IMAX IMAX Stock Holding History

Bayesian Capital Management’s Portfolio IMAX Stock Details IMAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,884
Closed -$370K – 910
2024
Q1 		$370K Buy
22,884
+10,500
+85% +$160K 0.04% 508
2023
Q4 		$186K Buy
+12,384
New +$212K 0.02% 614
2018
Q1 		– Sell
-24,800
Closed -$574K – 700
2017
Q4 		$574K Buy
+24,800
New +$584K 0.12% 289
2017
Q1 		– Sell
-11,011
Closed -$346K – 538
2016
Q4 		$346K Hold
11,011
– – 0.09% 392
2016
Q3 		$319K Buy
11,011
+3,300
+43% +$101K 0.21% 180
2016
Q2 		$227K Buy
+7,711
New +$242K 0.14% 293

Other funds holding IMAX

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCMF
Private Capital Management (Florida) Naples, Florida $1B AUM 15.98% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bayesian Capital Management's IMAX Position: Q2 2024 in Review

Bayesian Capital Management sold out of IMAX (IMAX) in Q2 2024, closing a stake of 22,884 shares — an estimated $370K sold.

Bayesian Capital Management first reported a position in IMAX in Q2 2016 and held it in 6 quarters. The position peaked at $574K in Q4 2017. 162 funds tracked by Wall St. Rank hold IMAX as of Q2 2024.

  • Bayesian Capital Management reported no remaining IMAX position as of Q2 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 22,884 IMAX shares in Q2 2024, an estimated $370K.
  • Bayesian Capital Management first reported a position in IMAX in Q2 2016 and held it in 6 quarters.
  • Bayesian Capital Management's IMAX position peaked at $574K in Q4 2017.
  • 162 funds tracked by Wall St. Rank held IMAX as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.